Jiyeon Kim
Jiyeon Kim
Assistant Professor at Yale University
Verified email at - Homepage
Cited by
Cited by
Lactate metabolism in human lung tumors
B Faubert, KY Li, L Cai, CT Hensley, J Kim, LG Zacharias, C Yang, QN Do, ...
Cell 171 (2), 358-371. e9, 2017
Metabolic Heterogeneity in Human Lung Tumors
Cell 164 (4), 681–694, 2016
Glutamine oxidation maintains the TCA cycle and cell survival during impaired mitochondrial pyruvate transport
C Yang, B Ko, CT Hensley, L Jiang, AT Wasti, J Kim, J Sudderth, ...
Molecular cell 56 (3), 414-424, 2014
Amino acids in cancer
EL Lieu, T Nguyen, S Rhyne, J Kim
Experimental & molecular medicine 52 (1), 15-30, 2020
Mechanisms and implications of metabolic heterogeneity in cancer
J Kim, RJ DeBerardinis
Cell metabolism 30 (3), 434-446, 2019
CPS1 maintains pyrimidine pools and DNA synthesis in KRAS/LKB1-mutant lung cancer cells
J Kim, Z Hu, L Cai, K Li, E Choi, B Faubert, D Bezwada, ...
Nature 546 (7656), 168-172, 2017
RUNX3 inactivation by point mutations and aberrant DNA methylation in bladder tumors
WJ Kim, EJ Kim, P Jeong, C Quan, J Kim, QL Li, JO Yang, Y Ito, SC Bae
Cancer research 65 (20), 9347-9354, 2005
Metabolic regulation of transcription through compartmentalized NAD+ biosynthesis
WLK Keun Woo Ryu, Tulip Nandu, Jiyeon Kim, Sridevi Challa, Ralph J. DeBerardinis
Science 360 (6389), eaan5780, 2018
Systematic identification of molecular subtype-selective vulnerabilities in non-small-cell lung cancer
HS Kim, S Mendiratta, J Kim, CV Pecot, JE Larsen, I Zubovych, BY Seo, ...
Cell 155 (3), 552-566, 2013
Inosine monophosphate dehydrogenase dependence in a subset of small cell lung cancers
F Huang, M Ni, MD Chalishazar, KE Huffman, J Kim, L Cai, X Shi, F Cai, ...
Cell metabolism 28 (3), 369-382. e5, 2018
Genotypes of TNF-α, VEGF, hOGG1, GSTM1, and GSTT1: useful determinants for clinical outcome of bladder cancer
EJ Kim, P Jeong, C Quan, J Kim, SC Bae, SJ Yoon, JW Kang, SC Lee, ...
Urology 65 (1), 70-75, 2005
Metabolic diversity in human non-small cell lung cancer cells
PH Chen, L Cai, K Huffman, C Yang, J Kim, B Faubert, L Boroughs, B Ko, ...
Molecular cell 76 (5), 838-851. e5, 2019
The hexosamine biosynthesis pathway is a targetable liability in KRAS/LKB1 mutant lung cancer
J Kim, HM Lee, F Cai, B Ko, C Yang, EL Lieu, N Muhammad, S Rhyne, ...
Nature metabolism 2 (12), 1401-1412, 2020
A network of substrates of the E3 ubiquitin ligases MDM2 and HUWE1 control apoptosis independently of p53
M Kurokawa, J Kim, J Geradts, K Matsuura, L Liu, X Ran, W Xia, TJ Ribar, ...
Science signaling 6 (274), ra32-ra32, 2013
Runt-related transcription factor RUNX3 is a target of MDM2-mediated ubiquitination
XZ Chi, J Kim, YH Lee, JW Lee, KS Lee, H Wee, WJ Kim, WY Park, BC Oh, ...
Cancer research 69 (20), 8111-8119, 2009
Rsk‐mediated phosphorylation and 14‐3‐3ε binding of Apaf‐1 suppresses cytochrome c‐induced apoptosis
J Kim, AB Parrish, M Kurokawa, K Matsuura, CD Freel, JL Andersen, ...
The EMBO journal 31 (5), 1279-1292, 2012
Oncology therapeutics targeting the metabolism of amino acids
N Muhammad, HM Lee, J Kim
Cells 9 (8), 1904, 2020
Identification of RUNX3 as a component of the MST/Hpo signaling pathway
B Min, MK Kim, JW Zhang, J Kim, KC Chung, BC Oh, GS Stein, YH Lee, ...
Journal of cellular physiology 227 (2), 839-849, 2012
RUNX family members are covalently modified and regulated by PIAS1-mediated sumoylation
JH Kim, JW Jang, YS Lee, JW Lee, XZ Chi, YH Li, MK Kim, DM Kim, ...
Oncogenesis 3 (4), e101-e101, 2014
Identification of gene expression signature modulated by nicotinamide in a mouse bladder cancer model
SK Kim, SJ Yun, J Kim, OJ Lee, SC Bae, WJ Kim
PloS one 6 (10), e26131, 2011
The system can't perform the operation now. Try again later.
Articles 1–20